Recombinant human insulin growth factor 1 (rhigf-1)    (DrugBank: Human insulin)

1 disease
IDDisease name (Link within this page)Number of trials
156Rett syndrome1

156. Rett syndrome    [ 36 clinical trials,   49 drugs,   (DrugBank: 19 drugs),   77 drug target genes,   112 drug target pathways]
Searched query = "Rett syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 36 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01777542
(ClinicalTrials.gov)
January 201323/1/2013Treatment of Rett Syndrome With Recombinant Human IGF-1Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)Rett SyndromeDrug: Recombinant Human Insulin Growth Factor 1 (rhIGF-1);Drug: PlaceboBoston Children's HospitalInternational Rett Syndrome FoundationCompleted2 Years10 YearsFemale30Phase 2United States